4.7 Article

Combined effects of MC4R and FTO common genetic variants on obesity in European general populations

期刊

JOURNAL OF MOLECULAR MEDICINE-JMM
卷 87, 期 5, 页码 537-546

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00109-009-0451-6

关键词

Obesity; SNP; Population genetics

资金

  1. French Government
  2. Agence Nationale de la Recherche
  3. Programme national de recherche sur le diabete
  4. CNAMTS
  5. Lilly
  6. Novartis Pharma
  7. Sanofi-Aventis
  8. INSERM
  9. Association Diabete Risque Vasculaire
  10. Federation Francaise de Cardiologie
  11. Fondation de France
  12. ALFEDIAM
  13. ONIVINS
  14. Ardix Medical
  15. Bayer Diagnostics
  16. Becton Dickinson
  17. Cardionics
  18. Merck Sant
  19. Novo Nordisk
  20. Pierre Fabre
  21. Roche
  22. Topcon
  23. Oulu University Hospital, Finland
  24. Academy of Finland
  25. European Commission [QLG1-CT- 2000-01643]
  26. MRC [G0600331] Funding Source: UKRI
  27. Medical Research Council [G0600331] Funding Source: researchfish

向作者/读者索取更多资源

Genome-wide association scans recently identified common polymorphisms, in intron 1 of FTO and 188 kb downstream MC4R, that modulate body mass index (BMI) and associate with increased risk of obesity. Although their individual contribution to obesity phenotype is modest, their combined effects and their interactions with environmental factors remained to be evaluated in large general populations from birth to adulthood. In the present study, we analyzed independent and combined effects of the FTO rs1421085 and MC4R rs17782313 risk alleles on BMI, fat mass, prevalence and incidence of obesity and subsequent type 2 diabetes (T2D) as well as their interactions with physical activity levels and gender in two European prospective population-based cohorts of 4,762 Finnish adolescents (NFBC 1986) and 3,167 French adults (D.E.S.I.R.). Compared to participants carrying neither FTO nor MC4R risk allele (20-24% of the populations), subjects with three or four risk alleles (7-10% of the populations) had a 3-fold increased susceptibility of developing obesity during childhood. In adults, their combined effects were more modest (similar to 1.8-fold increased risk) and associated with a 1.27% increase in fat mass (P = 0.001). Prospectively, we demonstrated that each FTO and MC4R risk allele increased obesity and T2D incidences by 24% (P = 0.02) and 21% (P = 0.02), respectively. However, the effect on T2D disappeared after adjustment for BMI. The Z-BMI and ponderal index of newborns homozygous for the rs1421085 C allele were 0.1 units (P = 0.02) and 0.27 g/cm(3) (P = 0.005) higher, respectively, than in those without FTO risk allele. The MC4R rs17782313 C allele was more associated with obesity and fat mass deposition in males than in females (P = 0.003 and P = 0.03, respectively) and low physical activity accentuated the effect of the FTO polymorphism on BMI increase and obesity prevalence (P = 0.008 and P = 0.01, respectively). In European general populations, the combined effects of common polymorphisms in FTO and MC4R are therefore additive, predictive of obesity and T2D, and may be influenced by interactions with physical activity levels and gender, respectively.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据